01/21/04 -- Protein arrays provide scientists with the ability to study protein expression and interactions in biomarker research towards the goal of developing novel therapeutics and diagnostics approaches. Researchers are currently becoming more familiar with protein array technologies and procedures, resulting in increased market growth. As the market evolves, researchers will desire an increased level of automation and integration.

New analysis from Frost & Sullivan (http://www.biotech.frost.com), World Protein Array Markets, reveals that this market generated revenues worth $87 million in 2002 and is likely to reach $575 million in 2009. This study presents a strategic analysis of the total protein array market, as well as specific forecasts for consumables and instruments. The forecast assumptions for this study are based on responses from an analysis of end users of protein array technology.

If you are interested in an analysis overview which provides manufacturers, end-users and other industry participants an overview, summary, challenges and latest coverage of the World Protein Array Markets -- then send an email to Danielle White - Healthcare Media Relations Executive at dwhite@frost.com with the following information: Full name, Company Name, Title, Contact Tel Number, Contact Fax Number, Email. Upon receipt of the above information, an overview will be emailed to you.

There are many challenges that need to be overcome in order for researchers to fully benefit from the use of protein arrays. Researchers view specificity, reproducibility and reliability as areas that require future technological advancement for them to more effectively attain their research goals. Despite these challenges, researchers continue to make significant research advances using protein array techniques.

"Arrays allow researchers to conduct experiments that they previously didn't think were possible. Through the use of arrays, researchers are able to study a greater number of systems at a greater speed and with more precision," says Frost & Sullivan Industry Analyst Sinead Igoe.

Protein arrays are expected to be a critical component of future disease research and in the development of molecular portraits of both diseased and healthy cells.

"Interaction studies are expected to become a more highly used application for protein arrays," notes Igoe.

Clinical proteomics is predicted to have an increased presence in the diagnostics market and will also enable researchers to more effectively discover biomarkers.

The World Protein Array Market analysis is part of the Proteomics Subscription, which also includes market insights on World Functional Proteomics Markets, Life Science Mass Spectrometry Markets, World Proteome Informatics Markets, and World Proteomics Sample Preparation Markets. Interviews are available to the press.

Frost & Sullivan, an international growth consultancy, has been supporting clients' expansion for more than four decades. Our market expertise covers a broad spectrum of industries, while our portfolio of advisory competencies includes custom strategic consulting, market intelligence and management training. Our mission is to forge partnerships with our clients' management teams to deliver market insights and to create value and drive growth through innovative approaches. Frost & Sullivan's network of consultants, industry experts, corporate trainers and support staff spans the globe with offices in every major country around the world.

Source: Frost & Sullivan